Clinical trial results have shown further that two GLP-1 receptor agonists (GLP-1 RAs), exenatide and liraglutide, which are approved for the treatment of hyperglycemia in patients with type 2 diabetes, also produce weight loss in overweight subjects without diabetes
Coupled with the cellular health benefits of fasting, we set the foundation for our body to accelerate maximal fat loss
Advances in analytical testing and molecular modeling may also help scientists better understand how compounds such as tirzepatide interact with different receptor systems
The demand for clean-label ingredients is another growing trend, particularly as more consumers on GLP-1 drugs seek health benefits from their treats
While Ozempic is not FDA-approved for weight management, its impact on appetite and metabolism has drawn attention beyond the diabetes community
Don't touch the stopper with your fingers after wiping